Jenburkt Pharmaceuticals Ltd (NSE: JENBURPH), ISIN INE354A01013 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
JENBURPH last traded at ₹1041.00 (-1.79%), with a 52-week range of ₹944.00 to ₹1340.00 (as of 30 Jul 2026).
Shareholding as of Dec 2025: promoters 46.65%, FIIs 0.00%, DIIs 0.12%, mutual funds 0.00%.
EquiSense Score (ECS): 75/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.